Replies to post #477726 on NorthWest Biotherapeutics Inc (NWBO)

[thermo]

I wasn’t trying to be insensitive, just practical. Shareholders should not just be yes votes on all issues, such as management compensation, incentive structures, etc. But voting against raising the share cap just leads down one of two paths: (i) the company runs out of money and things that must be done won’t be, or (ii) guys like me workaround the issue.

That said, I’d prefer the company minimize dilution because I would like to see all long-time shareholders get a nice return. I’ve expressed many times to company management how the shareholder base has been instrumental in getting the company through an expensive Phase 3 trial and that the company owes its shareholders every possible consideration (within the bounds of bringing DCVax to successful commercialization). I also think a successful commercialization will lead to a much higher share price.

Overall, I think the company is in a much stronger position than before and there are reasonable scenarios for a little more investment from financial players and then a segue into strategic discussions.

[Poor Man -]

That’s hitting the nail on the head - and as you can image, loose nails are an issue for me.

The company has to be transparent and offer a plan to shareholders that demonstrate a share increase is deserving from a commercial perspective. I just can’t see voting for an increase in authorized shares without commercial progress and a thoughtful case made to shareholders.

The expression throwing good money after bad also applies to endless dilution of shareholders.

Thermo- so common shareholders are hostage to whatever passes as a “plan?”

[biosectinvestor]

No original plan was abandoned. Read my other posts about release. There was no “release”, yet.